Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Benazepril hydrochloride 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benazepril hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benazepril hydrochloride 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely benazepril hydrochloride 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amlodipine besilate 2.5 milligram and benazepril hydrochloride 10 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amlodipine besilate 5 milligram and benazepril hydrochloride 10 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amlodipine besilate 5 milligram and benazepril hydrochloride 20 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benazepril hydrochloride 10 mg and hydrochlorothiazide 12.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benazepril hydrochloride 5 mg and hydrochlorothiazide 6.25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benazepril hydrochloride 20 mg and hydrochlorothiazide 12.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benazepril hydrochloride 20 mg and hydrochlorothiazide 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amlodipine besylate + benazepril hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing benazepril hydrochloride and hydrochlorothiazide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing benazepril hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amlodipine besilate 10 milligram and benazepril hydrochloride 20 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amlodipine besilate 10 milligram and benazepril hydrochloride 40 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amlodipine besilate 5 milligram and benazepril hydrochloride 40 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benazepril hydrochloride 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benazepril hydrochloride 5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benazepril hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benazepril hydrochloride 10 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benazepril hydrochloride 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benazepril hydrochloride 20 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely benazepril hydrochloride 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely benazepril hydrochloride 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benazepril hydrochloride 10 mg and hydrochlorothiazide 12.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Benazepril hydrochloride 10 mg and hydrochlorothiazide 12.5 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amlodipine besilate 2.5 milligram and benazepril hydrochloride 10 milligram/1 each conventional release oral capsule |
Has basis of strength substance (attribute) |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benazepril hydrochloride 5 mg and hydrochlorothiazide 6.25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benazepril hydrochloride 5 mg and hydrochlorothiazide 6.25 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benazepril hydrochloride 20 mg and hydrochlorothiazide 12.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Benazepril hydrochloride 20 mg and hydrochlorothiazide 12.5 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Benazepril hydrochloride 20 mg and hydrochlorothiazide 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benazepril hydrochloride 20 mg and hydrochlorothiazide 25 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amlodipine besilate 10 milligram and benazepril hydrochloride 20 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amlodipine besilate 10 milligram and benazepril hydrochloride 20 milligram/1 each conventional release oral capsule |
Has basis of strength substance (attribute) |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amlodipine besilate 10 milligram and benazepril hydrochloride 40 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amlodipine besilate 10 milligram and benazepril hydrochloride 40 milligram/1 each conventional release oral capsule |
Has basis of strength substance (attribute) |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amlodipine besilate 2.5 milligram and benazepril hydrochloride 10 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amlodipine besilate 2.5 milligram and benazepril hydrochloride 10 milligram/1 each conventional release oral capsule |
Has basis of strength substance (attribute) |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Benazepril hydrochloride 10 mg and hydrochlorothiazide 12.5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amlodipine besilate 5 milligram and benazepril hydrochloride 20 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amlodipine besilate 5 milligram and benazepril hydrochloride 20 milligram/1 each conventional release oral capsule |
Has basis of strength substance (attribute) |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amlodipine besilate 10 milligram and benazepril hydrochloride 20 milligram/1 each conventional release oral capsule |
Has basis of strength substance (attribute) |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amlodipine besilate 5 milligram and benazepril hydrochloride 40 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amlodipine besilate 5 milligram and benazepril hydrochloride 40 milligram/1 each conventional release oral capsule |
Has basis of strength substance (attribute) |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amlodipine besilate 5 milligram and benazepril hydrochloride 10 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amlodipine besilate 5 milligram and benazepril hydrochloride 10 milligram/1 each conventional release oral capsule |
Has basis of strength substance (attribute) |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amlodipine besilate 5 milligram and benazepril hydrochloride 20 milligram/1 each conventional release oral capsule |
Has precise active ingredient |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amlodipine besilate 10 milligram and benazepril hydrochloride 20 milligram/1 each conventional release oral capsule |
Has precise active ingredient |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Benazepril hydrochloride 20 mg and hydrochlorothiazide 25 mg oral tablet |
Has precise active ingredient |
True |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benazepril hydrochloride 5 mg oral tablet |
Has precise active ingredient |
True |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benazepril hydrochloride 10 mg oral tablet |
Has precise active ingredient |
True |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benazepril hydrochloride 20 mg oral tablet |
Has precise active ingredient |
True |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely benazepril hydrochloride 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amlodipine besilate 5 milligram and benazepril hydrochloride 40 milligram/1 each conventional release oral capsule |
Has precise active ingredient |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Benazepril hydrochloride 10 mg and hydrochlorothiazide 12.5 mg oral tablet |
Has precise active ingredient |
True |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benazepril hydrochloride 5 mg and hydrochlorothiazide 6.25 mg oral tablet |
Has precise active ingredient |
True |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benazepril hydrochloride 20 mg and hydrochlorothiazide 12.5 mg oral tablet |
Has precise active ingredient |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amlodipine besilate 5 milligram and benazepril hydrochloride 10 milligram/1 each conventional release oral capsule |
Has precise active ingredient |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amlodipine besilate 2.5 milligram and benazepril hydrochloride 10 milligram/1 each conventional release oral capsule |
Has precise active ingredient |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amlodipine besilate 10 milligram and benazepril hydrochloride 40 milligram/1 each conventional release oral capsule |
Has precise active ingredient |
False |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and benazepril hydrochloride 40 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and benazepril hydrochloride 40 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amlodipine (as amlodipine besilate) 5 mg and benazepril hydrochloride 20 mg oral capsule |
Has precise active ingredient |
True |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amlodipine (as amlodipine besilate) 5 mg and benazepril hydrochloride 20 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and benazepril hydrochloride 40 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and benazepril hydrochloride 40 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and benazepril hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and benazepril hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and benazepril hydrochloride 20 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and benazepril hydrochloride 20 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amlodipine (as amlodipine besilate) 2.5 mg and benazepril hydrochloride 10 mg oral capsule |
Has precise active ingredient |
True |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amlodipine (as amlodipine besilate) 2.5 mg and benazepril hydrochloride 10 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benazepril hydrochloride 20 mg and hydrochlorothiazide 12.5 mg oral tablet |
Has precise active ingredient |
True |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benazepril hydrochloride 20 mg and hydrochlorothiazide 12.5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Benazepril hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |